JW Cayman Therapeutics Company Limited (药明巨诺（开曼）有限公司) is a company in China, with a head office in Shanghai. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was first established on September 06, 2017. JW Cayman Therapeutics Company Limited (药明巨诺（开曼）有限公司) currently employs 281 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 22.5% in Q2C2025. A negative growth of 28.3% was recorded in its total assets. JW Cayman Therapeutics Company Limited (药明巨诺（开曼）有限公司)’s net profit margin increased by 25.44% in 2025.
Headquarters
4F, Building 42, No. 225 Meisheng Road, Pilot Free Trade Zone, Prc
Shanghai; Shanghai;
Contact Details: Purchase the JW Cayman Therapeutics Company Limited (药明巨诺（开曼）有限公司) report to view the information.
Website: http://www.jwtherapeutics.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service